GI Innovation, Inc. (KOSDAQ:358570)
15,200
+90 (0.60%)
At close: Mar 6, 2026
GI Innovation Market Cap
GI Innovation has a market cap or net worth of 974.15 billion as of March 6, 2026. Its market cap has increased by 68.88% in one year.
Market Cap
974.15B
Enterprise Value
943.39B
Revenue
338.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
15,200.00
Market Cap Chart
Since March 30, 2023, GI Innovation's market cap has increased from 445.59B to 974.15B, an increase of 118.62%. That is a compound annual growth rate of 30.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 974.15B | -13.51% |
| Dec 30, 2025 | 1,126.31B | 187.90% |
| Dec 30, 2024 | 391.21B | -26.45% |
| Dec 28, 2023 | 531.89B | 19.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 793.23B |
| Onconic Therapeutics | 776.56B |
| Pharmicell | 758.45B |
| MEDIPOST | 723.08B |
| Proteina | 678.25B |
| Green Cross Holdings | 623.37B |
| Chabiotech | 1,587.97B |
| Orum Therapeutics | 2,208.17B |